Healthcare M&A news: healthcare mergers and acquisitions in 2026
Every healthcare merger, acquisition, take-private and carve-out we have verified in 2026, newest first. Updated every morning.
CD&R and McKesson → Option Care Health$5.8bnSTERIS → Xodus Medical$2.1bnShionogi → IntraBio$2bnSamsung Biologics → PolyPeptide Group AG$1.8bnViatris → Pacira BioSciences$1.7bnGalderma → ZO Skin Health$1.5bnToho Holdings → PHC Holdings$1.3bnLabcorp Holdings Inc. → BioReference Health (select assets, from OPKO Health)$722mAgilent Technologies → Proscia$240mMankind Pharma Limited (via Mankind Pharma (Netherlands) B.V.) → Armed Cell Therapeutics B.V. (ACTx) – 70% stake$56mBoston Scientific Corporation → Penumbra, Inc.$14.5bnSun Pharmaceutical Industries Ltd → Organon & Co.$11.8bn
124Deals tracked
$224.2bnDisclosed value
$14.5bnLargest deal
79Completed
Healthcare M&A news: healthcare mergers and acquisitions in 2026
- 16 Oct 2026Samsung Biologics' PolyPeptide offer succeeds with 87.9%Samsung Biologics → PolyPeptide Group AGHealthcare / Pharma CDMOAgreed$1.8bn
- 16 Oct 2026Parkview Health agrees to acquire Ovation HealthcareParkview Health → Ovation HealthcareHealthcare / Hospital servicesAgreedUndisclosed
- 15 Oct 2026Labcorp agrees to buy BioReference testing assets for up to US$872mLabcorp Holdings Inc. → BioReference Health (select assets, from OPKO Health)Healthcare / DiagnosticsAgreed$722m
- 15 Oct 2026Mankind Pharma takes 70% of Belgian CAR-T developer ACTx for €48mMankind Pharma Limited (via Mankind Pharma (Netherlands) B.V.) → Armed Cell Therapeutics B.V. (ACTx) – 70% stakeHealthcare / BiotechAgreed$56m
- 14 Oct 2026Galderma agrees $1.5bn deal for Blackstone-backed ZO Skin HealthGalderma → ZO Skin HealthHealthcare / DermatologyAgreed$1.5bn
- 13 Oct 2026Agilent agrees to buy digital pathology firm Proscia for up to US$270mAgilent Technologies → ProsciaHealthcare / Digital pathology softwareAgreed$240m
- 12 Oct 2026STERIS agrees US$2.1bn deal for Xodus MedicalSTERIS → Xodus MedicalHealthcare / Medical devicesAgreed$2.1bn
- 9 Oct 2026Toho walks away from US$1.3bn PHC takeoverToho Holdings → PHC HoldingsHealthcare / Medical devices and diagnosticsTerminated$1.3bn
- 9 Oct 2026Midea completes takeover of Italian imaging group EsaoteMidea Group → EsaoteHealthcare / Medical imagingCompletedUndisclosed
- 8 Oct 2026Viatris agrees $1.65bn cash deal for Pacira BioSciencesViatris → Pacira BioSciencesHealthcareAgreed$1.7bn
- 7 Oct 2026CVC and GBL raise Recordati bid to final €53 a shareRespighi BidCo (CVC, GBL) → RecordatiHealthcareIn reviewUndisclosed
- 6 Oct 2026CD&R and McKesson agree $5.8bn buyout of Option Care HealthCD&R and McKesson → Option Care HealthHealthcareAgreed$5.8bn
- 5 Oct 2026Shionogi to buy IntraBio for about $2bnShionogi → IntraBioHealthcare / PharmaAgreed$2bn
- 1 Oct 2026Fresenius takes full control of mAbxience for up to EUR750mFresenius → mAbxience (remaining 45%)Healthcare / BiosimilarsCompletedUndisclosed
- 23 Sept 2026Bio-Techne shareholders back $11.3bn sale to Merck KGaAMerck KGaA → Bio-TechneHealthcare / Life-science toolsIn review$11.3bn
- 20 Sept 2026Telix agrees up to $2.35bn deal for Munich's ITMTelix Pharmaceuticals → ITM Isotope Technologies MunichHealthcare / RadiopharmaAgreed$2.4bn
- 17 Sept 2026Eurobio Scientific's owner moves to delist at €25.30 a shareEB Development → Eurobio ScientificHealthcareAnnouncedUndisclosed
- 31 Aug 2026Lilly agrees up to US$2.9bn deal for Merida BiosciencesEli Lilly and Company → Merida BiosciencesHealthcare / BiotechAgreedUndisclosed
- 25 Aug 2026McKesson agrees US$2.25bn deal for Precision Medicine GroupMcKesson Corporation → Precision Medicine GroupHealthcare / Clinical research servicesAgreed$2.3bn
- 18 Aug 2026BioMarin agrees US$275m upfront deal for Alesta TherapeuticsBioMarin Pharmaceutical Inc. → Alesta TherapeuticsHealthcare / BiotechCompleted$275m
- 18 Aug 2026Medbase takes control of ArdentisMedbase Group → Ardentis (majority stake)Healthcare / Dental clinicsCompletedUndisclosed
- 17 Aug 2026Manipal Health agrees INR 1.3bn deal for Kinder Women's HospitalManipal Health Enterprises Limited → Kinder Women's Hospital and Fertility Centre, Bengaluru (business of Kindorama Healthcare)Healthcare / HospitalsAgreed$14m
- 11 Aug 2026Alfasigma agrees to buy Nordic PharmaAlfasigma S.p.A. → Nordic Group B.V. (Nordic Pharma)Healthcare / Specialty pharmaAgreedUndisclosed
- 10 Aug 2026Teledyne agrees US$1.1bn deal for Varex ImagingTeledyne Technologies → Varex ImagingHealthcare / Medical imaging componentsAgreed$1.1bn
- 10 Aug 2026Jazz agrees US$820m deal for Actio BiosciencesJazz Pharmaceuticals plc → Actio BiosciencesHealthcare / BiotechAgreed$820m
- 6 Aug 2026KKR agrees €1.2bn deal for Medicover's Indian hospitalsKKR → Medicover Hospitals IndiaHealthcare / HospitalsAgreed$1.4bn
- 6 Aug 2026Tarsus agrees US$450m deal for AlkeusTarsus Pharmaceuticals → Alkeus PharmaceuticalsHealthcare / BiotechCompleted$450m
- 6 Aug 2026iRhythm agrees US$288m deal for VitalConnectiRhythm Holdings → VitalConnectHealthcare / Medical devicesCompleted$288m
- 5 Aug 2026NIC fund launches ¥26.2bn take-private of CE HoldingsNippon Investment Company (NIC Fund, via SK-03) → CE Holdings Co., Ltd.Healthcare / Medical information systemsAgreed$170m
- 3 Aug 2026Curium agrees up to US$8bn deal for LantheusCurium → Lantheus HoldingsHealthcare / RadiopharmaceuticalsAgreed$7.5bn
- 3 Aug 2026KKR agrees US$5.7bn take-private of IntegerKKR → Integer Holdings CorporationHealthcare / Medical device manufacturingAgreed$5.7bn
- 29 Jul 2026MiMedx agrees US$350m deal for Sanara MedTechMiMedx Group, Inc. → Sanara MedTech Inc.Healthcare / Medical devicesAgreed$350m
- 27 Jul 2026argenx completes US$2.2bn Forte Biosciences acquisitionargenx SE → Forte Biosciences, Inc.Healthcare / BiotechCompleted$2.2bn
- 22 Jul 2026Repligen completes US$1.5bn BioLife Solutions acquisitionRepligen Corporation → BioLife Solutions, Inc.Healthcare / Life science toolsCompleted$1.5bn
- 20 Jul 2026Tempus agrees US$1.5bn deal for PersonalisTempus AI, Inc. → Personalis, Inc.Healthcare / DiagnosticsAgreed$1.5bn
- 20 Jul 2026Dubai Investments takes full ownership of Clemenceau Medical Center DubaiDubai Investments PJSC → Clemenceau Medical Center Dubai (80%)Healthcare / HospitalsCompletedUndisclosed
- 16 Jul 2026Lilly completes AtaiBeckley takeover worth up to US$3.8bnEli Lilly and Company → AtaiBeckley Inc.Healthcare / BiotechCompleted$2.8bn
- 13 Jul 2026Warburg Pincus-led group agrees to buy control of PANTHERx RareWarburg Pincus-led investor group → PANTHERx RareHealthcare / Specialty pharmacyAgreedUndisclosed
- 7 Jul 2026EQT agrees to buy TachoSil business from Corza MedicalEQT (EQT X) → Corza Biosurgery (TachoSil)Healthcare / Surgical biologicsAgreedUndisclosed
- 6 Jul 2026Vertex completes US$10bn takeover of CrineticsVertex Pharmaceuticals Incorporated → Crinetics Pharmaceuticals, Inc.Healthcare / BiotechCompleted$10bn
- 6 Jul 2026Novartis buys Myricx Bio for up to US$1.5bnNovartis AG → Myricx BioHealthcare / BiotechCompleted$1.1bn
- 29 Jun 2026Ipsen agrees up to US$1.75bn deal for Kartos TherapeuticsIpsen S.A. → Kartos Therapeutics, Inc.Healthcare / BiotechCompleted$450m
- 25 Jun 2026H.B. Fuller agrees £659m takeover of Advanced Medical SolutionsH.B. Fuller Company → Advanced Medical Solutions Group plcHealthcare / Medical devicesAgreed$867m
- 25 Jun 2026Advent buys Japan Wellbeing from MBK in first Japan dealAdvent International → Japan Wellbeing Corp.Healthcare / Elderly careAgreedUndisclosed
- 22 Jun 2026AbbVie agrees US$10.9bn deal for Apogee TherapeuticsAbbVie Inc. → Apogee Therapeutics, Inc.Healthcare / BiotechCompleted$10.9bn
- 17 Jun 2026Biogen agrees up to US$1bn deal for RayTheraBiogen Inc. → RayThera Inc.Healthcare / BiotechCompletedUndisclosed
- 16 Jun 2026Altaris to take Simulations Plus private for US$375mAltaris → Simulations Plus, Inc.Healthcare / Drug development softwareAgreed$375m
- 10 Jun 2026Aster DM Healthcare takes control of Saudi Arabia's ProCare HospitalAster DM Healthcare (GCC) → ProCare HospitalHealthcare / HospitalsCompletedUndisclosed
- 9 Jun 2026GSK agrees US$10.6bn deal for NuvalentGSK plc → Nuvalent, Inc.Healthcare / BiotechCompleted$10.6bn
- 9 Jun 2026Novanta agrees US$1.45bn deal for Riverpoint MedicalNovanta Inc. → Riverpoint MedicalHealthcare / Medical devicesCompleted$1.2bn
- 8 Jun 2026Incyte agrees up to US$2bn deal for Vega TherapeuticsIncyte Corporation → Vega Therapeutics, Inc. (subsidiary of Star Therapeutics)Healthcare / BiotechCompleted$1.3bn
- 8 Jun 2026Johnson & Johnson agrees US$1bn deal for Firefly BioJohnson & Johnson → Firefly Bio, Inc.Healthcare / BiotechCompleted$1bn
- 5 Jun 2026GNI Group buys Ayumi Pharmaceutical from Blackstone for ¥44.8bnGNI Group → Ayumi Pharmaceutical HoldingsHealthcare / PharmaceuticalsCompleted$280m
- 1 Jun 2026Servier agrees up to US$2.65bn deal for Edgewise's sevasemtenServier → Edgewise Therapeutics' muscular dystrophy business (sevasemten)Healthcare / BiotechCompleted$1.6bn
- 26 May 2026Olympus pays US$270m for Israel's BioProtectOlympus Corporation → BioProtect Ltd.Healthcare / Medical devicesCompleted$270m
- 26 May 2026Lilly agrees deal worth up to US$1.5bn for shingles vaccine maker CurevoEli Lilly and Company → Curevo, Inc.Healthcare / VaccinesAgreedUndisclosed
- 26 May 2026Lilly agrees up-to-US$780m deal for Swiss vaccine maker LimmaTechEli Lilly and Company → LimmaTech Biologics AGHealthcare / VaccinesAgreedUndisclosed
- 26 May 2026Stonepeak consortium agrees to buy Estia Health from BainStonepeak-led consortium (with Axight Capital) → Estia HealthHealthcare / Aged careAgreedUndisclosed
- 20 May 2026Medtronic agrees US$650m deal for SPR TherapeuticsMedtronic plc → SPR Therapeutics, Inc.Healthcare / Medical devicesCompleted$650m
- 18 May 2026Boston Scientific invests US$1.5bn in MiRus with TAVR buyout optionBoston Scientific Corporation → MiRus LLC (c.34% stake, with option on TAVR business)Healthcare / Medical devicesCompleted$1.5bn
- 18 May 2026Mehiläinen agrees to buy Aleris from TritonMehiläinen Group → Aleris GroupHealthcare / Specialist care providersAgreedUndisclosed
- 7 May 2026Angelini Pharma agrees US$4.1bn deal for Catalyst PharmaceuticalsAngelini Pharma S.p.A. → Catalyst Pharmaceuticals, Inc.Healthcare / Rare disease pharmaceuticalsCompleted$4.1bn
- 7 May 2026Roche agrees deal worth up to US$1.05bn for PathAIRoche Holding AG → PathAI, Inc.Healthcare / Digital pathologyAgreed$750m
- 7 May 2026Artivion exercises option to buy Endospan after NEXUS approvalArtivion, Inc. → Endospan Ltd.Healthcare / Medical devicesCompleted$135m
- 6 May 2026Knox Lane takes Cross Country Healthcare private for US$437mKnox Lane → Cross Country Healthcare, Inc.Healthcare / StaffingCompleted$437m
- 6 May 2026Polpharma agrees €270m takeover of Romania's BiofarmZakłady Farmaceutyczne Polpharma S.A. → Biofarm S.A.Healthcare / Generic pharmaceuticalsCompleted$320m
- 6 May 2026Bayer agrees deal worth up to US$2.45bn for Perfuse TherapeuticsBayer AG → Perfuse Therapeutics, Inc.Healthcare / BiotechCompleted$300m
- 3 May 2026UCB agrees deal worth up to US$2.2bn for Candid TherapeuticsUCB S.A. → Candid Therapeutics, Inc.Healthcare / BiotechCompleted$2bn
- 1 May 2026ArchiMed agrees up to US$1.1bn take-private of EsperionArchiMed → Esperion Therapeutics, Inc.Healthcare / PharmaceuticalsCompleted$1bn
- 29 Apr 2026Chiesi agrees US$1.9bn takeover of KalVistaChiesi Farmaceutici S.p.A. → KalVista Pharmaceuticals, Inc.Healthcare / BiotechCompleted$1.9bn
- 29 Apr 2026Teva agrees up-to-US$900m deal for Tourette drug developer EmalexTeva Pharmaceutical Industries Ltd → Emalex BiosciencesHealthcare / BiotechCompleted$900m
- 27 Apr 2026Astorg buys Thermo Fisher's microbiology business for US$1.075bnAstorg (Astorg VIII) → Thermo Fisher Scientific microbiology business (Oxoid and Remel)Healthcare / DiagnosticsCompleted$1.1bn
- 27 Apr 2026Ligand agrees US$739m takeover of XOMA RoyaltyLigand Pharmaceuticals Incorporated → XOMA Royalty CorporationHealthcare / Biopharma royaltiesCompleted$739m
- 27 Apr 2026Lilly agrees up-to-US$2.3bn deal for JAK2 specialist AjaxEli Lilly and Company → Ajax Therapeutics, Inc.Healthcare / BiotechCompletedUndisclosed
- 26 Apr 2026Sun Pharma agrees US$11.75bn takeover of OrganonSun Pharmaceutical Industries Ltd → Organon & Co.Healthcare / PharmaceuticalsIn review$11.8bn
- 24 Apr 2026J&J agrees to buy left-heart access specialist Atraverse MedicalJohnson & Johnson → Atraverse Medical, Inc.Healthcare / Medical devicesCompletedUndisclosed
- 23 Apr 2026IKS Health agrees to buy rural hospital software provider TruBridgeInventurus Knowledge Solutions (IKS Health) → TruBridge, Inc.Healthcare / Health ITCompletedUndisclosed
- 22 Apr 2026Amneal agrees up-to-US$1.1bn deal for biosimilars maker KashivAmneal Pharmaceuticals, Inc. → Kashiv BioSciences, LLCHealthcare / BiosimilarsCompleted$750m
- 20 Apr 2026Lilly agrees up-to-US$7bn deal for in vivo CAR-T developer KeloniaEli Lilly and Company → Kelonia Therapeutics, Inc.Healthcare / BiotechCompleted$3.3bn
- 17 Apr 2026UCB agrees up-to-US$1.15bn deal for epilepsy cell therapy developer NeuronaUCB SA → Neurona Therapeutics Inc.Healthcare / BiotechCompleted$650m
- 16 Apr 2026Charterhouse agrees £235m take-private of veterinary group AnimalcareCharterhouse Capital Partners (CCP Paw 2) → Animalcare Group plcHealthcare / Veterinary pharmaceuticalsCompleted$320m
- 14 Apr 2026American Industrial Partners agrees US$1.27bn take-private of Avanos MedicalAmerican Industrial Partners → Avanos Medical, Inc.Healthcare / Medical devicesCompleted$1.3bn
- 14 Apr 2026Everstone invests US$270m in Indian generics maker ApotheconEverstone Capital → Apothecon Group (Apothecon Pharmaceuticals and Navinta)Healthcare / Generic pharmaceuticalsAgreed$270m
- 13 Apr 2026Revenio agrees €290m deal for VisionixRevenio Group Oyj → Visionix (LT International SAS)Healthcare / Ophthalmic diagnosticsCompleted$339m
- 7 Apr 2026Gilead agrees up to US$5bn deal for TubulisGilead Sciences, Inc. → Tubulis GmbHHealthcare / BiotechCompleted$3.2bn
- 6 Apr 2026Neurocrine agrees US$2.9bn takeover of Soleno TherapeuticsNeurocrine Biosciences, Inc. → Soleno Therapeutics, Inc.Healthcare / BiotechCompleted$2.9bn
- 31 Mar 2026Lilly agrees up to US$7.8bn deal for CentessaEli Lilly and Company → Centessa Pharmaceuticals plcHealthcare / BiotechCompleted$6.3bn
- 31 Mar 2026Biogen agrees US$5.6bn deal for ApellisBiogen Inc. → Apellis Pharmaceuticals, Inc.Healthcare / BiotechCompleted$5.6bn
- 27 Mar 2026Otsuka agrees deal worth up to US$1.2bn for Transcend TherapeuticsOtsuka Pharmaceutical Co., Ltd. → Transcend Therapeutics, Inc.Healthcare / BiotechCompleted$700m
- 27 Mar 2026Novartis agrees deal worth up to US$2bn for ExcellergyNovartis AG → Excellergy, Inc.Healthcare / BiotechCompletedUndisclosed
- 25 Mar 2026Merck agrees US$6.7bn deal for Terns PharmaceuticalsMerck & Co., Inc. → Terns Pharmaceuticals, Inc.Healthcare / BiotechCompleted$6.7bn
- 23 Mar 2026Gilead agrees US$1.7bn deal for Ouro MedicinesGilead Sciences, Inc. → Ouro MedicinesHealthcare / BiotechCompleted$1.7bn
- 20 Mar 2026Novartis agrees US$2bn deal for Synnovation's PI3Kα unitNovartis AG → Pikavation Therapeutics (Synnovation Therapeutics)Healthcare / BiotechCompleted$2bn
- 19 Mar 2026Collegium agrees US$650m deal for ADHD drug AZSTARYSCollegium Pharmaceutical, Inc. → AZSTARYS (Corium Therapeutics)Healthcare / PharmaceuticalsCompleted$650m
- 17 Mar 2026Strides buys Sandoz branded generics in Sub-Saharan AfricaStrides Pharma Science Limited (via Strides Pharma International AG) → Sandoz branded generics portfolio in Sub-Saharan AfricaHealthcare / Generic pharmaceuticalsAgreed$12m
- 16 Mar 2026Amplifon agrees €2.3bn deal for GN HearingAmplifon S.p.A. → GN Hearing (GN Store Nord)Healthcare / Hearing aidsAgreed$2.6bn
- 9 Mar 2026Agilent agrees US$950m deal for Biocare MedicalAgilent Technologies Inc. → Biocare MedicalHealthcare / DiagnosticsCompleted$950m
- 9 Mar 2026UHS agrees US$835m deal for TalkspaceUniversal Health Services, Inc. → Talkspace, Inc.Healthcare / Behavioural healthCompleted$835m
- 6 Mar 2026Lone Star agrees CHF2.3bn carve-out of Lonza's capsules armLone Star Funds (Lone Star Fund XII) → Lonza Capsules & Health Ingredients (60%)Healthcare / Capsules and nutrition ingredientsAgreed$3bn
- 6 Mar 2026Servier agrees US$2.5bn deal for Day One BiopharmaceuticalsServier → Day One Biopharmaceuticals, Inc.Healthcare / BiotechCompleted$2.5bn
- 2 Mar 2026WCAS and Select Medical founders agree $3.9bn take-privateWelsh, Carson, Anderson & Stowe, Robert A. Ortenzio and Martin F. Jackson → Select Medical Holdings CorporationHealthcare / Rehabilitation and critical illness recoveryCompleted$3.9bn
- 2 Mar 2026Gyre agrees US$300m all-stock deal for CullgenGyre Therapeutics, Inc. → Cullgen Inc.Healthcare / BiotechCompleted$300m
- 2 Mar 2026RadNet buys Gleamer for up to €230mRadNet, Inc. → Gleamer SASHealthcare / Radiology AICompleted$269m
- 26 Feb 2026Asahi Kasei agrees €780m deal for AiCurisAsahi Kasei Corporation → AiCuris Anti-infective Cures AGHealthcare / BiotechCompleted$920m
- 25 Feb 2026GSK agrees US$950m deal for 35PharmaGSK plc → 35Pharma Inc.Healthcare / BiotechCompleted$950m
- 23 Feb 2026Gilead agrees US$7.8bn deal for ArcellxGilead Sciences, Inc. → Arcellx, Inc.Healthcare / BiotechCompleted$7.8bn
- 23 Feb 2026Kinderhook agrees $1.1bn take-private of EnhabitKinderhook Industries → Enhabit, Inc.Healthcare / Home health and hospiceCompleted$1.1bn
- 18 Feb 2026Covetrus agrees US$3.5bn merger with Cencora's MWI Animal HealthCovetrus, Inc. → MWI Animal Health (Cencora)Healthcare / Animal health distributionIn review$3.5bn
- 18 Feb 2026Organigram agrees €113m deal for Sanity GroupOrganigram Global Inc. → Sanity Group GmbHHealthcare / Medical cannabisCompleted$134m
- 18 Feb 2026Dr. Reddy's enters hormone therapy with $32m Progynova purchaseDr. Reddy's Laboratories Ltd → Progynova and Cyclo-Progynova India brands (Mercury Pharma Group)Healthcare / PharmaceuticalsCompleted$32m
- 17 Feb 2026Danaher agrees US$9.9bn deal for MasimoDanaher Corporation → Masimo CorporationHealthcare / Medical devicesCompleted$9.9bn
- 16 Feb 2026Optima Health agrees £100m deal for PAM HealthcareOptima Health plc → PAM Healthcare LimitedHealthcare / Occupational healthCompleted$136m
- 13 Feb 2026Takara Holdings bids ¥54bn to take Takara Bio privateTakara Holdings Inc. → Takara Bio Inc.Healthcare / Life science toolsCompleted$353m
- 13 Feb 2026Alkem buys majority of Swiss heart-implant maker Occlutech for €99.4mAlkem Laboratories Ltd (Alkem MedTech) → Occlutech Holding AG (majority stake)Healthcare / Medical devicesCompleted$118m
- 9 Feb 2026Lilly agrees up to US$2.4bn deal for Orna TherapeuticsEli Lilly and Company → Orna Therapeutics, Inc.Healthcare / BiotechCompleted$2.4bn
- 28 Jan 2026Sword Health buys Munich's Kaia Health for $285mSword Health → Kaia HealthHealthcare / Digital therapeuticsCompleted$285m
- 23 Jan 2026Nissha agrees to buy control of Vietnam's USM HealthcareNissha Co., Ltd. → USM Healthcare Medical Devices Factory JSCHealthcare / Medical devicesCompletedUndisclosed
- 20 Jan 2026GSK agrees US$2.2bn deal for food allergy biotech RAPTGSK plc → RAPT Therapeutics, Inc.Healthcare / BiotechCompleted$2.2bn
- 15 Jan 2026Boston Scientific agrees US$14.5bn deal for PenumbraBoston Scientific Corporation → Penumbra, Inc.Healthcare / Medical devicesIn review$14.5bn
- 14 Jan 2026EQT abandons pursuit of Oxford BiomedicaEQT X fund → Oxford Biomedica plcHealthcare / Cell and gene therapy manufacturingTerminatedUndisclosed
- 12 Jan 2026Smith+Nephew agrees up to US$450m deal for Integrity OrthopaedicsSmith & Nephew plc → Integrity Orthopaedics, Inc.Healthcare / Medical devicesCompleted$450m
- 12 Jan 2026Boston Scientific agrees to buy eCoin maker Valencia TechnologiesBoston Scientific Corporation → Valencia Technologies CorporationHealthcare / Medical devicesCompletedUndisclosed
- 7 Jan 2026Lilly agrees US$1.2bn deal for Ventyx BiosciencesEli Lilly and Company → Ventyx Biosciences, Inc.Healthcare / BiotechCompleted$1.2bn
- 6 Jan 2026Amgen buys UK protein-degrader biotech Dark Blue for up to $840mAmgen Inc. → Dark Blue TherapeuticsHealthcare / BiotechCompleted$840m